We are aware that the suspension of these popular prescription drug plans may affect many of our customers that were intent on using Anthem as their insurance provider
Fort Collins, Colo. (PRWEB) February 4, 2009
As of January 12, 2009, Anthem Blue Cross has been ordered to suspend its Medicare Advantage and Medicare Part D Services by the Centers for Medicare and Medicare Services (CMS) - a U.S. federal agency that administers the federal Medicare and Medicaid programs as well as the State Children's Health Insurance Program. The suspension affects individuals planning on enrolling in the programs across the country, but will not impact current plan members.
Medicare Advantage (MA), Medicare Advantage Prescription Drug (MAPD), and Prescription Drug Plans (PDP) are designed to help millions of Americans afford their medications. According to CMS, there are more than 25 million Medicare beneficiaries enrolled in the Part D program alone. The suspension of the program will deny many new Anthem members' access to pharmacy insurance benefits that they would otherwise be able to get through their insurance coverage, but may not impact individuals that enroll with other insurance carriers.
Gap coverage may help some Americans to afford their prescriptions as well. According to data compiled in 2008 by CMS, 13 percent of non-LIS enrollees in PDPs and 63 percent of enrollees in MAPDs had gap coverage in addition to their base health insurance plans. Companies such as Medigap Advisors, help individuals to determine which health care plans, including gap coverage plans, are right for their clients, even as the availability of coverage options changes.
"We are aware that the suspension of these popular prescription drug plans may affect many of our customers that were intent on using Anthem as their insurance provider," said Wiley Long, President of MediGap Advisors. "However, we will work with each of our clients to ensure that they get a plan that best suits their lifestyle and financial needs."
According to CMS, Medicaid spending is expected to rise at a faster rate than the economy at an average rate of nearly eight percent over the next decade, compared to a less than five percent growth rate of the federal economy. By 2017, CMS projects that Medicaid spending will reach $674 annually and nearly five trillion over the next decade.
More About MediGap Advisors
MediGap Advisors offers affordable healthcare and prescription drug coverage programs for Medicare and Medicaid enrollees across the country. Product offerings that help clients afford their health care include gap coverage, health savings accounts, programs for employers and employees, and more. For more information about Medigap Advisors visit: http://www.MediGapAdvisors.com